Wang Hongwei, Xu Minghui, Kong Qingjie, Sun Peng, Yan Fengyun, Tian Wenying, Wang Xin
Department of Ophthalmology, People's Hospital of Jingjiang, Jingjiang, Jiangsu 214500, P.R. China.
Library, Qiqihar Medical University, Qiqihar, Heilongjiang 161006, P.R. China.
Mol Med Rep. 2017 Jul;16(1):11-22. doi: 10.3892/mmr.2017.6600. Epub 2017 May 18.
Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC‑2, including CLCN2, ClC‑2 promoter and the structural properties of ClC‑2 protein; physiological properties; functional properties, including the regulation of cell volume. The effects of ClC‑2 on the digestive, respiratory, circulatory, nervous and optical systems are also discussed, in addition to the mechanisms involved in the regulation of ClC‑2. The review then discusses the diseases associated with ClC‑2, including degeneration of the retina, Sjögren's syndrome, age‑related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus. It was concluded that future investigations of ClC‑2 are likely to be focused on developing specific drugs, activators and inhibitors regulating the expression of ClC‑2 to treat diseases associated with ClC‑2. The determination of CLCN2 is required to prevent and treat several diseases associated with ClC‑2.
氯离子通道2(ClC-2)是ClC家族九个哺乳动物成员之一。本综述讨论了ClC-2的分子特性,包括CLCN2、ClC-2启动子和ClC-2蛋白的结构特性;生理特性;功能特性,包括细胞体积调节。此外,还讨论了ClC-2对消化、呼吸、循环、神经和视觉系统的影响以及ClC-2调节的机制。该综述接着讨论了与ClC-2相关的疾病,包括视网膜变性、干燥综合征、年龄相关性白内障、睾丸变性、无精子症、肺癌、便秘、受损肠黏膜屏障修复、白血病、囊性纤维化、白质脑病、癫痫和糖尿病。得出的结论是,未来对ClC-2的研究可能集中在开发调节ClC-2表达的特异性药物、激活剂和抑制剂以治疗与ClC-2相关的疾病。为预防和治疗几种与ClC-2相关的疾病,需要对CLCN2进行测定。